# Palvella Therapeutics, Inc.: Form 8-K, filed Jun 30, 2026

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: 8-K
- Filed: 2026-06-30
- Accepted by EDGAR: Jun 30, 2026, 07:36 ET
- Period: 2026-06-29
- Accession: 0001104659-26-079087
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/tm2619348d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/tm2619348d1_8k.htm

Filed Jun 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-079087. Last ingested by Listed: Nov 5, 2026, 12:13 ET. No prices; not investment advice.